TABLE 3.
Subject’s individual liver enzyme values (in units per L; U/L) at baseline (−30 min) and after the session (300 min) are displayed for day 4 (largest dose). ASAT/GOT, aspartate aminotransferase/glutamic oxaloacetic transaminase; ALAT/GPT, alanine transaminase/glutamate-pyruvate transaminase; GAMMA-GT, gamma-glutamyl transferase.
| Liver enzymes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Day 4 | Subject (#) | |||||||||
| Timepoint | Analyt | Reference | #3 | #4 | #5 | #6 | #7 | #8 | #9 | #10 |
| Baseline (t-30) | ASAT/GOT (U/L) | <37 | 17 | 22 | 21 | 17 | 23 | 17 | 17 | 20 |
| ALAT/GPT (U/L) | <65 | 18 | 16 | 23 | 24 | 20 | 24 | 16 | 31 | |
| GAMMA-GT (U/L) | <85 | 17 | 15 | 17 | 18 | 16 | 18 | 14 | 14 | |
| After session (t300) | ASAT/GOT (U/L) | <37 | 19 | 25 | 20 | 29 | 23 | 18 | 16 | 20 |
| ALAT/GPT (U/L) | <65 | 17 | 17 | 23 | 25 | 20 | 25 | 16 | 36 | |
| GAMMA-GT (U/L) | <85 | 16 | 15 | 16 | 18 | 17 | 19 | 12 | 16 | |
The bold numbers indicate the clinical threshold values. Concentrations higher than the reference values indicate a clinically relevant increase in the liver enzyme concentration.